Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are raising expectations that...
Search results for "clinical trial"
Nurse-Led 5-Day Program Cuts Fall Risk for Older Patients in No-Guardian Wards
Researchers have developed an intervention model aimed at sharply reducing fall risks among hospitalized older adults in integrated nursing and...
Zinc and Selenium Deficiencies Linked to Heightened Inflammation in Critically Ill Patients
For families with loved ones in an intensive care unit , lab reports often feature unfamiliar line items alongside...
Don’t Ignore a Weaker Handshake: 1 in 4 Adults Over 80 Has Sarcopenia
When holding your parents' hands, a noticeably weaker grip should not be brushed off as a harmless part of aging.
550 Days in Limbo: Groups Demand 100-Day Fast-Track Insurance Coverage for Breakthrough PAH Drug Winrevair
With national health insurance coverage for the new pulmonary arterial hypertension treatment Winrevair (active...
Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27
Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's...
VOYXACT Preserves Kidney Function for Two Years in Phase 3 IgA Nephropathy Trial
Otsuka Pharmaceutical’s VOYXACT (active ingredient: sibeprenlimab) demonstrated long-term kidney protection by...
HK inno.N's K-CAB Secures Sixth Indication to Prevent Ulcers from Long-Term NSAID Use
HK inno.N’s gastroesophageal reflux disease drug K-CAB has expanded its approved uses to include the prevention of...
AI Tracks Lung Scarring: 4-Percentage-Point Rise in One Year Signals Danger
Researchers have established an artificial intelligence benchmark to quantify the progression of idiopathic pulmonary...
Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia
OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C...